Name of Drug Classification Adverse effect Indication Contraindication Nursing Considerations

It is effective for the

Cefuroxime ANTIINFECTIVE; Body as a Whole: treatment of Hypersensitivity to  Determine history of
IV 50mg q6 ANTIBIOTIC; Thrombophlebitis penicillinase- cephalosporins and related hypersensitivity
SECOND- (IV site); pain, producing Neisseria antibiotics; pregnancy reactions to
GENERATION burning, cellulitis gonorrhoea (category B), lactation. cephalosporins,
CEPHALOSPORIN (IM site); (PPNG). Effectively penicillins, and history
superinfections, treats bone and of allergies, particularly
positive Coombs' joint infections, to drugs, before
test. bronchitis, therapy is initiated.
GI: Diarrhea, meningitis,  Inspect IM and IV
nausea, antibiotic- gonorrhea, otitis injection sites
associated colitis. media, frequently for signs of
Skin: Rash, pharyngitis/tonsillitis phlebitis.
pruritus, urticaria. , sinusitis, lower  Report onset of loose
Urogenital: respiratory tract stools or diarrhea.
Increased serum infections, skin and Although
creatinine and soft tissue pseudomembranous
BUN, decreased infections, urinary colitis.
creatinine tract infections, and  Monitor I&O rates and
clearance. is used for surgical pattern: Especially
prophylaxis, important in severely ill
reducing or patients receiving high
eliminating doses. Report any
infection. significant changes.
 Classification Adverse effect Indication Contraindication Nursing Consideration
Name of Drug

Assessment & Drug Effects

 Monitor for S&S of
Ambroxol Mucolytic Occasional Adjuvant therapy in There are no absolute aspiration of excess
0.5m tid gastrointestinal patients with contraindication but in secretions, and for
side effects may abnormal, viscid, or patients with gastric bronchospasm
occur but these are inspissated mucous ulceration relative caution (unpredictable);
almost invariably secretions in acute should be observed. withhold drug and
mild. and chronic notify physician
bronchopulmonary immediately if either
diseases, and in occur.
pulmonary  Lab tests: Monitor
complications of ABGs, pulmonary
cystic fibrosis and functions and pulse
surgery, oximetry as indicated.
tracheostomy, and  Have suction
atelectasis. Also apparatus
used in diagnostic immediately available.
bronchial studies Increased volume of
and as an antidote respiratory tract fluid
for acute may be liberated;
acetaminophen suction or
poisoning. endotracheal
aspiration may be
necessary to establish
and maintain an open
airway.
Patient & Family Education
  Report difficulty with
clearing the airway or
any other respiratory
distress.

DRUGNAME: Classificatio Mechanism of INDICATION/CON ROUTES/ ADVERSE EFFECTS Side NURSING

n Action TRAINDICATION DOSAGE OF THE DRUG Effects RESPONSIBILITIE
S /PRECAUTIONS
Fine tremor of Headache, *Assess cardio-
Generic Name: Functional:P Ipraprotium Dosage:1 skeletal muscles, dizziness, respiratory function:
Ipraprotium arasympath bromide:Antichol INDICATIONS nebule 2.5 palpitations, dryness of heart rate and
SalbutamolBra olyticBronch inergic, mgRoute:Ne nervousness, mouth, throat rhythm, respiration
nd odilatorAntic chemically COMBIVENT bulizationFre urinary retention, irritation, rate and breathing
Name:Combiv holinergicCh related to Inhalation Aerosol quency:Q8H dyspnea, nausea, pattern, and breath
ent emical:Adre atropine, which is indicated for use exacerbation of vomiting, GI sounds.Note
nergic blocks vagally in patients with symptoms, upset adventitious
beta2- mediated chronic obstructive allergic-type sounds.
agonist, reflexes by pulmonary disease reactions *Ensure adequate
sympathomi antagonizing the (COPD) on a hydration; provide
metic, action of regular aerosol ventilation to
bronchodilat acetylcholine. bronchodilator who prevent
or Causes continue to have hyperpyrexia.
bronchodilation evidence of *Do not double
and inhibits bronchospasm doses or increase
secretion from and who require a the frequency of
serous and second doses. Drug should
seromucous bronchodilator. be given exactly as
glands lining the prescribed.Perform
 nasal mucosa. Contraindication chest physiotherapy
Salbutamol:Stim Hypersensitivity to after nebulization.
ulates beta-2 the drug, *Report rash, eye
receptors of tachyarrythmias, pain, palpitations,
bronchioles to hypertrophic tremors, weakness,
produce obstructive irregular
bronchodilation cardiomyopathies, heartbeat.Provide
hypersensitivity to proper nutrition.
atropine Give small frequent
feedings for GI
upset/nausea/vomiti
ng.

DRUGNAME: Classificatio Mechanism of INDICATION/CON ROUTES/ ADVERSE EFFECTS Side NURSING

n Action TRAINDICATION DOSAGE OF THE DRUG Effects RESPONSIBILITIE
S /PRECAUTIONS
GENERIC  glucocortico Budesonide is a The budesonide inhaler  The most commonly noted side  The most
id steroid  man-made inhaler is used for effects associated with inhaled commonly noted
NAME: glucocorticoid the control of budesonide are mild cough or side effects
budesonide steroid related to asthma in persons wheezing; these effects may be associated with
the naturally- requiring minimized by using a bronchodilator inhaled budesonide
BRAND occurring continuous, inhaler, for example, albuterol are mild cough or
NAME: hormone, prolonged (Ventolin), prior to the budesonide. wheezing; these
cortisol or treatment. Such Oral candidiasis or thrush (a fungal effects may be
Pulmicort hydrocortisone patients may infection of the throat) may occur in 1 minimized by using
Turbuhaler, which is include those with in 25 persons who use budesonide a bronchodilator
Pulmicort produced in the frequent asthmatic without a spacer device on the inhaler inhaler, for
adrenal glands. episodes requiring example, albuterol
Respules
It is used for bronchodilators, (Ventolin), prior to
treating asthma for the budesonide.
by inhalation example, albuterol  Oral candidiasis
(Ventolin) or those or thrush (a fungal
with asthmatic infection of the
episodes at night. throat) may occur in
1 in 25 persons who
use budesonide
without a spacer
device on the
inhaler
Name of Drug Classification Adverse effect Indication Contraindication Nursing Considerations

Brand name: No CNS Bronchial asthma &

Ansimar Antiasthmatic & COPD and CVS side pulmonary disease Adrenergic bronchodilators Assess lung sounds, pulse and
Generic name: Preparations effects. w/ spastic bronchial and phosphodiesterase blood pressure before
Doxofylline Doxofyllin component. inhibitors both work by administration and during peak
e has a prolonged increasing intracellular of medication. Not amount,
bronchodilator level of cyclic-3’,5’- color, and character of sputum
effects and unlike adenosine monophosphate produced.
theophylline it has (cAMP); adrenergics by
least adenosine increasing production and Monitor pulmonary function
interactions. phosphodiesterase tests before initiating therapy
It is highly inhibitors by decreasing and periodically during therapy
safe in smokers. breakdown. Increased to determine effectiveness of
There is levels of cAMP produce medication.
no sleep bronchodilation.
disturbances and Corticosteroids act by Observe for paradoxical
no effects on decreasing airway bronchospasm (wheezing). If
gastric secretions inflammation. conditions occur, withhold
with doxofylline. Anticholinergics medication and notify physician
(ipratropium) produce of other health care
brondhodilation by professional immediately.
decreasing intracellular
levels of cyclic guanosine
monophosphate (cGMP).
Leukotriene receptor
antagonists and mast cell
stabilizers decrease the
release of substances that
can contribute to
bronchospasm.
Name of Drug Classification Adverse effect Indication Contraindication Nursing Considerations

Brand name: hypervitaminosis may color urine

Moriamin Forte multivitamins and (large doses) yellow contraindicated for Assess patient for signs of
Generic name: minerals patient’s with vitamin deficiency before and
Calcium malabsorption syndrome periodically throughout therapy.
pantothenic Assess nutritional status
through 24 h diet recall.
Determine frequency of
consumption of vit rich foods
Name of Drug Classification Adverse effect Indication Contraindication Nursing Considerations

Appetitmangel.
Einzelstoffe 1 Drg. enth.: c
Pizotifenhydrogenmalat
Generic: 0,73 mg (entspr.
Mosegor 0,5 mg Base).
Name of Drug Classification Adverse effect Indication Contraindication Nursing Considerations

Generic Name: Rifampicin: "flu- For the continuation

Anti-infectives/ like" syndrome phase treatment of Hypersensitivity. Jaundice . Neutropenia has been
Ethambutol, Antituberculosis/Antilep (such as, fever, all forms of or severe liver disease. reported in a patient on
Isoniazid, ros chills, sometimes pulmonary and Pre-existing optic neuritis ethambutol,isoniazid, and
Rifampicin with headache, extrapulmonary rifampicin. Each drug induced
dizziness, and tuberculosis. neutropenia individually on
bone pain); rechallenge. 
hematopoietic
reactions (such as,
leukopenia,
thrombocytopenia,
and acute
hemolytic anemia);
cutaneous;
Gastrointestinal
and hepatic
reactions; dyspnea,
wheezing; shock;
and acute renal
failure. Elevations
in serum
concentrations of
alanine
transaminase,
aspartate
transaminase,
bilirubin, and
alkaline
phosphatase,
asymptomatic
jaundice, and
 hepatitis.

Name of Drug Classification Adverse effect Indication Contraindication Nursing Considerations

CV: Postural
FUROSEMIDE ELECTROLYTIC AND hypotension, Treatment of edema History of hypersensitivity
(fur-oh'se-mide) WATER BALANCE dizziness with associated with to furosemide or Assessment & Drug Effects
AGENT; LOOP excessive diuresis, CHF, cirrhosis of sulfonamides; increasing
Fumide , DIURETIC acute hypotensive liver, and kidney oliguria, anuria, fluid and  Observe patients receiving
Furomide , Lasix, episodes, disease, including electrolyte depletion states; parenteral drug carefully;
Luramide  circulatory nephrotic hepatic coma; pregnancy closely monitor BP and vital
collapse. syndrome. May be (category C), lactation. signs. Sudden death from
Metabolic: used for cardiac arrest has been
Hypovolemia, management of reported.
dehydration, hypertension, alone  Monitor BP during periods
hyponatremia or in combination of diuresis and through period
hypokalemia, with other of dosage adjustment.
hypochloremia antihypertensive  Observe older adults
metabolic alkalosis, agents, and for closely during period of brisk
hypomagnesemia, treatment of diuresis. Sudden alteration in
hypocalcemia hypercalcemia. Has fluid and electrolyte balance
(tetany), been used may precipitate significant
hyperglycemia, concomitantly with adverse reactions. Report
glycosuria, mannitol for symptoms to physician.
elevated BUN, treatment of severe  Lab tests: Obtain frequent
hyperuricemia. GI: cerebral edema, blood count, serum and urine
Nausea, vomiting, particularly in electrolytes, CO2, BUN, blood
oral and gastric meningitis. sugar, and uric acid values
burning, anorexia,
during first few months of
diarrhea,
therapy and periodically
constipation,
thereafter.
abdominal
 Monitor for S&S of
cramping, acute
pancreatitis, hypokalemia.
jaundice.  Monitor I&O ratio and
Urogenital: Allergic pattern. Report decrease or
interstitial nephritis, unusual increase in output.
irreversible renal Excessive diuresis can result
failure, urinary in dehydration and
frequency. hypovolemia, circulatory
Hematologic: collapse, and hypotension.
Anemia, Weigh patient daily under
leukopenia, standard conditions.
thrombocytopenic  Monitor urine and blood
purpura; aplastic glucose & HbA1C closely in
anemia, diabetics and patients with
agranulocytosis decompensated hepatic
(rare). Special cirrhosis. Drug may cause
Senses: Tinnitus, hyperglycemia.
vertigo, feeling of
fullness in ears,
hearing loss (rarely
permanent),
blurred vision. Skin:
Pruritus, urticaria,
exfoliative
dermatitis, purpura,
photosensitivity,
porphyria cutanea
tarde, necrotizing
angiitis (vasculitis).
Body as a Whole:
Increased
perspiration;
paresthesias;
activation of SLE,
muscle spasms,
weakness;
thrombophlebitis,
 pain at IM injection
site.

DRUG INDICATION CONTRAINDICATION SIDE EFFECTS NURSING CONSIDERATIONS

Drug name: -atrial fibrillation -hypersensitivity -anorexia -monitor v/s
-digoxin ACTION -intermittent complete heart block -GI disturbance -should be administered with
Brand name: -(+) inotrophic effect more -2nd heart block -atrial tachycardia food or after eating
-lanoxin available calcium promotes -gynecomastia -watch out for the adverse
Doctor’s order: increase forces to increase -CNS effect reaction of drug
-0.25mg 1tab OD cardiac output

DRUG INDICATION CONTRAINDICATION SIDE EFFECTS NURSING

CONSIDERATIONS
Arcoxia
etoricoxib
Adult: PO Osteoarthritis 60 mg once
daily. Rheumatoid arthritis 90 mg once
daily. Acute gout 120 mg once daily.
Max duration: 8 days.
GI disorders; ischemic
cardiac events;
hypersensitivity reactions,
headache, dizziness,
Allergic disorders,
nervousness, depression,
Inflammatory bowel disease, coagulation defects;
drowsiness, insomnia,
severe congestive heart history of cardiac failure,
vertigo, tinnitus,
failure, active peptic left ventricular dysfunction,
photosensitivity; blood
ulceration, cerebrovascular hypertension, or in patients
disorders, fluid retention,
disease, CrCL <30 ml/min; with oedema due to other
hypertension; dry mouth,
lactation. Children and reasons; elderly, renal,
taste disturbance, mouth
adolescent < 16 yr cardiac or hepatic
ulcers; appetite and wt
impairment
changes; chest pain, fatigue,
paraesthesia, influenza-like
syndrome, myalgia. Renal
toxicity
Generic /Brand name Classification Dosage, Timing, Indication Mechanism of Adverse reaction Nursing
Route Action responsibilities
 nausea, vomiting,
TRAMADOL Analgesics 50mg IVTT q 8hrs Moderate to • Assess type, location,
sweating
(9/20/10) moderately severe • Binds to mu-opioid and constipation. and intensity of pain before
pain
receptors. Drowsiness is and 2-3 hr (peak) after
reported, although it
• Inhibits reuptake of is less of an issue administration.
serotonin and than for non- • Assess bowel function
synthetic opioids.
norepinephrine in routinely. • Assess
Contraindication Patients prescribed
the CNS tramadol for general previous analgesic history.
pain relief with or
Tramadol is not
without other agents
Health recommended for patients
have reported
professionals have
not yet fully withdrawal dependent on opioids or
endorsed of its use symptoms including
uncontrollable who have previously
on a large scale for
these disorders, nervous tremors, received opioids for more
although it may be muscle contracture,
used when other than 1 wk; may cause
and 'thrashing' in
treatments have bed (similar to opioid withdrawal
failed (under the restless leg
supervision of a symptoms.
psychiatrist).
syndrome.
• • Monitor patient
for seizures. May occur
within recommended dose
range. Risk increased with
higher doses and
inpatients taking
antidepressants (SSRIs,
tricyclics, or Mao
inhibitors), opioid
analgesics, or other durgs
that decrese the seizure
 threshold.
• Overdose may cause
respiratory depression
and seizures.
• Encourage patient to
cough and breathe deeply
every 2 hr to prevent
atelactasis and pneumonia.

NURSING
GENERIC NAME INDICATION AND DOSAGE ACTION CONTRAINDICATION SIDE EFFECTS
CONSIDERATION
Ranitidine HCL •Active Duodenal Ulcer •Completely inhibits •Contraindicated in •CNS: headache, •Instruct patient on
Adults: PO 150mg b.i.d. or 300 mg at action of histamine patients malaise, vertigo proper use of OTC
bedtime. Maintenance dose is 150 mg on the H2 at hypersensitive to preparation as
at bedtime. IM/IV/Intermittent IV 50 receptor sites of drug and those with •EENT: Blurred vision, indicated.
mg every 6 to 8 h. parietal cells, porphyria •Assess patient for
Children 1 mon -16 y/o: PO 2 to 4 decreasing gastric •Use cautiously in •Hepatic: jaundice abdominal pain. Note
mg/kg twice daily (max, 300 acid secretions patients with hepatic presence of blood in
mg/day). dysfunction. Adjust emesis, stool, or gastric
•Other: anaphylaxis,
•Maintenance therapy for Duodenal dose in patients with aspirate
angioedema, burning ad
and Gastric Ulcers impaired renal •Ranitidine may be
itching at injection site
Adults: 150mg P.O at bedtime function added to total
Children 1 mon -16 y/o: PO 2 to 4 parenteral nutrition
mg/kg daily up to 150mg daily solution
•Pathologic Hypersecretory •Remind patient to take
Conditions once daily prescription
Adults: PO 150 mg twice daily. drug at bedtime for
Individualize. best results
•GERD and Erosive Esophagitis •Instruct patient to take
Adults: PO 150mg b.i.d. without regard to meals
Children 1 mon -16 y/o: PO 5 to 10 because absorption
mg/kg daily usually given in 2 divided isn’t affected by food
 doses. • Remind patient not to
•Erosive Esophagitis: Maintenance confuse ranitidine with
dosage is 150mg P.O. q.i.d. rimantadine: don’t
•Heartburn confuse Zantac with
Adults and Children 1 mon -12 y/o Xanax or Zyrtec
and older: 75mg of Zantac 75 P.O. as
symptoms occur, up to 150mg daily,
not to exceed 2 weeks of continuous
treatment.

GENERIC
INDICATION AND DOSAGE
NAME
Nalbuphin •Management of moderate to
e HCL severe pain
•preoperative and
postoperative analgesia
•supplement to balanced
anesthesia
•obstetrical analgesia during
labor and delivery
DOSAGE
Adults Subcutaneous / IM / IV
10 mg per 70 kg q 3 to 6 h as
needed. Individualize dosage.
In nontolerant patients, do not
exceed 20 mg/dose or 160  hypertension, hypotension,
mg/day
ACTION CONTRAINDICATION
•Binds with •Contraindicated in patients
opiate hypersensitive to drug
receptors in the •Use cautiously in patients
CNS, altering with history of drug abuse
perception of and in those with emotional
and emotional instability, head injury,
response to increased ICP, impaired
pain. ventilation, MI accompanied
by N/V, upcoming biliary
surgery, and hepatic or renal
disease
SIDE EFFECTS
• CNS: Sedation, dizziness,
vertigo, headache, agitation,
confusion, crying, depression,
dysphoria, euphoria,
faintness, floating feeling,
hallucinations, heaviness
feeling, hostility,
nervousness, numbness,
restlessness, seizures,
tingling, unreality, unusual
dreams
•CV: Bradycardia,
tachycardia
•EENT: Blurred vision, dry
mouth
•GI: Nausea, vomiting,
biliary tract spasms,
constipation cramps,
dyspepsia
NURSING CONSIDERATION
•Reassess patient’s level of
pain at least 15 and 30
minutes after parenteral
administration
•Nalbuphine acts as an opioid
antagonist and may cause
withdrawal syndrome. For
patients who have received
log-term opioids, give 25% of
the usual dose initially. Watch
for sings of withdrawal.
•Alert: Drug causes respiratory
depression, which at 10mg is
equal to respiratory depression
produced by 10 mg of
morphine
•Monitor circulatory and
respiratory status, bladder and
bowel function. If respirations
are shallow or rate is below 12
breaths/minute, withhold dose
and notify prescriber
•Constipation is often severe
with maintenance therapy.
Make sure stool softener or
other laxative is ordered.

•GU: Urinary urgency
•Respiratory: Respiratory
depression, asthma,
dyspnea, pulmonary edema
•Psychological and physical
dependence may occur with
prolonged use.
• Remind patient not to
confuse Nubain with Navane.

•Skin: Burning, clamminess,

diaphoresis, pruritus, uticaria
Name of Drug Classification & Contraindication & Drug to Drug Nursing
Indication Adverse Reaction Interaction Responsibilities

Methergine Classification: Contraindication: Antifungals like: 1. Before

(Methylergonovine Maleate) PC: Ergot Alkaloid  Pregnancy  Azole administering
and Derivative  Toxemia (litraconazole, the methergine,
Dosage: TC: oxytoxic,  Hypertension ketoconazole, give only if the
0.6 mg/3 ml lactation stimulant  Ergot vericonazole) – solution is clear
hypersensitivity Increase risk of and colorless;
Preparation: Indication:  To include labor vasospasm leading discard if
Intramascular Management and and spontaneous to cerebral ischemia ampule is
prevention of abortions. or ischemia of discolored.
postpartum and  Administration extremities; do not 2. Note reason for
postabortal before delivery of use together. therapy. List
hemorrhage by placenta.  Clarithomycin – drug prescribe
producing firm Increase risk of to ensure none
 Use with CYP3A4
uterine contractions vasospasm leading interact.
inhibitors.
and decreasing to cerebral ischemia 3. Assess fundal
uterine bleeding. or ischemia of tone and
Indication:
extremities; do not nonphasic
 Headache
use together. contractures,
 Dizziness massage to
 Erythomycins –
 Sweating check for
Increase risk of
 Nasal Congestion relaxation or
vasospasm leading
 Leg cramps to cerebral ischemia severe
and ischemia of cramping.
extremities; do not 4. Monitor Vital
use together. Signs, CBC,
 Protease and calcium;
inhibitors – increase Correct if low
risk of vasospasm to improve
leading to cerebral drug
ischemia or effectiveness
ischemia of and assess for
extremities; do not decrease milk
use together. production.
5. Report
frequency,
amount, color,
any associated
S&S. Ensure
placenta
completely
passed or
removed.
6. Take only
directed and do
not exceed
dosage
7. Report any
severe
cramping,
headaches, or
increase
bleeding.
8. Evaluate for
improved
uterine tone
 and control of
postpartum
hemorrhage.

Drug Data Classification Indication Contraindications Adverse Reaction Nursing Responsibilities

Generic Pharmacologic Class - Antepatum: to initiate - significant CV: Cardiac arryhtsmias, PVCs, Before
Name Hormone or improve uterine cephalopelvic HPN, subarachnoid hemorrhage - Assess for significant cephalopelvic
Oxytocin contractions to achieve disproportion, Fetal effects: Fetal bradycaria, disproportion, unfavorable fetal positions or
Therapeutic Class early vaginal delivery; unfavorable fetal neonatal jaundice, low Apgar presentations, severe toxemia, uterine
Trade Oxytocic stimulation or positions or scores inertia, hypertonic uterine patterns, previous
Name reinforcement of labor presentations, GI: nausea, vomiting cesarean section
Pitocin Pregnancy category in selected cases of obstetric GU: postpartum hemorrhage, - Assess fetal heart rate, uterine tone
X uterine inertia; emergencies that uterine rupture, pelvic hematoma, - Ensure fetal position and size and absence
Content management of favor surgical uterine hypertonicity, spasm, tetanic of complications.
Synthetic inevitable or intervention, contraction, rupture of the uterus
oxytocin incomplete abortion; prolonged use in with excessive dosage, or During
second trimester severe toxemia, hypersensitivity - Infuse via constant infusion pump to
abortion uterine inertia, Hypersensitivity: Anaphylactic ensure accurate control of rate; rate
- Postpartum: To hypertonic uterine reactions determined by uterine response; begin with
produce uterine patterns, induction Other: Maternal and fetal deaths 1-2mL/min and increase at 16- to 60-min
contractions during the or ougmentation of when used to induce labor or in 1st intervals
third stage of labor and labor when vaginal or 2nd stages of labor; - Do not combine in solution with fibrinolysin
to control postpartum delivery is afibrinogemia; severe water or heparin
bleeding or contraindicated, intoxication with seizures and - Monitor maternal BP
hemorrhage. previous cesarean coma, maternal death - Monitor neonate for jaundice
- lactation deficiency section, pregnancy - Discontinue drug and notify physician at
- Unlabeled use; To (nasal) any sign of hypertensive emergency
evaluate fetal distress
(oxytocin challenge Use cautiously with After
test), treatment off renal impairment. - Educate client on the side effects of the
breast engorgement medication and what to expect.
- Document that drug has been given.
 DRUG INDICATION CONTRAINDICATION SIDE EFFECTS NURSING
CONSIDERATIONS
Drug name: -essential hypertension -hypersensitivity to the drug -diarrhea -special precaution in
-telmisartan, ACTION -2nd and 3rd trimester of -anorexia patients with impaired
hydrochlorothiazide -blocks the pregnancy -loss of appetite hepatic and renal
Brand name: vasoconstrictive and -lactation -gastric irritation impairment
-micardis plus aldosterone-secreting -constipation -special precaution with
Doctor’s order: effects of angotensin II by volume and/or Na-
-40mg 1tab OD binding angiotensin II to depleted patients
the AT I receptor in many -may impair ability to
tissue. drive or operate
machineries

DRUG INDICATION CONTRAINDICATION SIDE EFFECTS NURSING

CONSIDERATIONS
Drug name: -angina pectoris -sick-sinus syndrome -nausea -monitor v/s especially the
-diltiazem ACTION -2nd and 3rd AV block -swelling/edema BP
Brand name: -inhibits calcium ion -severe hypotension -arrhythmia -should be administered
-cordazem influx across cell -pregnancy -headache with food or after eating
Doctor’s order: membrane during cardiac -rash
-90mg 1tab BID depolarization, produces -fatigue
relaxation of coronary
arteries, slows SA/AV
node conduction times,
dilates peripheral arteries.

DRUG INDICATION CONTRAINDICATION SIDE EFFECTS NURSING CONSIDERATIONS

Tranexamic acid
short term management of severe renal failure, active intravascular > diarrhea, N/V > Incompatible with benzylpenicillin
hemorrhage clotting, thromboembolic disease, colour > disturbances in color vision > may be taken with or without food
vision disorders, subarachnoid bleeding > giddiness > monitor eye examination regularly
> hypotension (after rapid IV injection) during long term use
> discontinue if changes in color vision
occurs
> avoid IV injection rate of more than 1
ml/minute due to risk of hypotension
> monitor bleeding